Abstract
Hadel Mahroos Alghabban
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Immune escape after hematopoietic stem cell transplantation (HSCT): From mechanisms to novel therapies
10.3390/cancers12010069 · 2019
Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD
10.1038/s41571-020-0356-4 · 2020
CNS-targeting therapies for lysosomal storage diseases: Current advances and challenges
10.3389/fmolb.2020.559804 · 2020
A review of acute and long-term neurological complications following haematopoietic stem cell transplant for paediatric acute lymphoblastic leukaemia
10.3389/fped.2021.774853 · 2021
Stem cell transplantation therapy and neurological disorders: Current status and future perspectives
2022
Noninfectious neurologic complications after allogeneic hematopoietic stem cell transplantation
10.1016/j.bbmt.2019.05.024 · 2019
High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease
10.1038/s41409-018-0293-3 · 2019
Strengths and challenges of longitudinal non-human primate neuroimaging
10.1016/j.neuroimage.2021.118009 · 2021
Mental status changes after hematopoietic stem cell transplantation
10.1002/cncr.24496 · 2009
Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with β-thalassemia: a case series and review of literature
10.1186/s13244-024-01605-y · 2024
Improved brain pathology and progressive peripheral neuropathy in a 15 year old survivor of infantile krabbe disease treated with umbilical cord transplantation
10.3389/fnmol.2022.888231 · 2022
Advances in therapies for neurological lysosomal storage disorders
10.1002/jimd.12615 · 2023
Mucopolysaccharidosis IVA: Diagnosis, treatment, and management
10.3390/ijms21041517 · 2020
Stem cell therapy for post-traumatic stress disorder: A novel therapeutic approach
10.3390/diseases9040077 · 2021
Induced pluripotent stem cell-derived neural progenitor cell transplantation promotes regeneration and functional recovery after post-traumatic stress disorder in rats
10.1016/j.biopha.2020.110981 · 2021
Associations between executive functioning, personality, and posttraumatic stress symptoms in adolescent solid organ transplant recipients
10.1111/petr.14176 · 2022
Neurocognitive impairment after hematopoietic stem cell transplant for hematologic malignancies: phenotype and mechanisms
10.1002/onco.13867 · 2021
Recent Topics on The mechanisms of immunosuppressive therapy-related neurotoxicities
10.3390/ijms20133210 · 2019
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study
10.1038/s41591-022-02097-3 · 2023
Depicting the anatomy of the gyral white matter: ubi sumus? quo vadimus
10.1093/braincomms/fcad265 · 2023
Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients
10.1038/s41409-021-01365-z · 2021
Neuroimaging and psychometric assessment of mild cognitive impairment after traumatic brain injury
10.3389/fpsyg.2020.01423 · 2020
Tractography-based analysis of morphological and anatomical characteristics of the uncinate fasciculus in human brains
10.3390/brainsci10100709 · 2020
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells
10.1038/s41571-020-00456-y · 2021
White matter abnormalities in paediatric obsessive-compulsive disorder: a systematic review of diffusion tensor imaging studies
10.1007/s11682-023-00761-x · 2023
Autologous hematopoietic stem cell transplantation in multiple sclerosis patients: Monocentric case series and systematic review of the literature
10.3390/jcm11040942 · 2022
Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis
10.1002/ajh.27297 · 2024
Rehabilitation before and after autologous haematopoietic stem cell transplantation (ahsct) for patients with multiple sclerosis (ms): consensus guidelines and recommendations for best clinical practice on behalf of the autoimmune diseases working party, nurses group, and patient advocacy committee of the european society for blood and marrow transplantation (ebmt)
10.3389/fneur.2020.556141 · 2020
Neurocognitive functioning in long-term survivors of pediatric hematopoietic cell transplantation
10.1038/s41409-020-01125-5 · 2021
Cognitive functioning in survivors of hematopoietic stem cell transplantation compared with a matched general population sample-the maastricht observational study of late effects after stem cell transplantation study
10.1016/j.jtct.2023.03.026 · 2023
Long term disease burden post-transplantation: Three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT)
10.1186/s13023-020-01644-w · 2021
Abstracts of the 5th sfcns congress—swiss federation of clinical neuro-societies basel, Switzerland, September 28–30, 2022
10.3390/ctn6030022 · 2022
Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation
2021
Cognitive complaints by hematopoietic cell transplantation recipients and change in neuropsychological performance over time
2021
French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases
10.1016/j.revmed.2023.12.008 · 2024
Survival protection of patients undergoing hematopoietic stem cell transplantation: grounded theory
2023
Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT
10.1038/s41409-021-01539-9 · 2022
Hematopoietic stem cell factors: their functional role in self-renewal and clinical aspects
10.3389/fcell.2022.664261 · 2022
Stiff-person syndrome and gad antibody-spectrum disorders: gabaergic neuronal excitability, immunopathogenesis and update on antibody therapies
10.1007/s13311-022-01188-w · 2022
Transcranial magnetic stimulation as a diagnostic and therapeutic tool in various types of dementia
10.3390/jcm10132875 · 2021
New autoimmune disorder development after immune reconstitution therapy for multiple sclerosis
10.1038/s41598-024-82196-y · doi-reference
Persistent impairment in immune reconstitution and worse survival outcomes in allogeneic stem cell transplantation patients with early coronavirus disease 2019 infection
10.1016/j.jtct.2024.04.021 · doi-reference
Gender and the length of time since autologous hematopoietic stem cell transplantation-What is their influence on the immune reconstitution in multiple myeloma patients
10.1371/journal.pone.0295308 · doi-reference
Sexual dimorphism in immune cell responses following stroke
10.1016/j.nbd.2022.105836 · doi-reference
Concise Review: The high cost of high tech medicine: Planning ahead for market access
10.1002/sctm.16-0487 · doi-reference
Cost Effectiveness of Hematopoietic Stem Cell Transplantation Compared with Transfusion Chelation for Treatment of Thalassemia Major
10.1016/j.bbmt.2018.04.005 · doi-reference
Breaking barriers: Supporting hematopoietic stem cell transplant program through collaborative radiation therapy service from a physically distant center
10.1186/s43046-024-00221-7 · doi-reference
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy
10.1002/acn3.51796 · doi-reference
The management of pain during pediatric hematopoietic stem cell transplantation: A qualitative study of contextual factors that influenced pain management practices
10.1002/pbc.30614 · doi-reference
Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: a study protocol for a randomised controlled phase-II trial (the FMT-allo study)
10.1136/bmjopen-2022-068480 · doi-reference
Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation
10.1182/bloodadvances.2022009632 · doi-reference
Patients´ experiences and perspectives of challenges and needs related to nonmyeloablative stem cell transplantation: Involving patients in developing a targeted rehabilitation programme
10.1111/jocn.14739 · doi-reference
Impact of cognitive rehabilitation on cognitive and functional outcomes in adult cancer survivors: A systematic review
10.1016/j.soncn.2024.151696 · doi-reference
Neuroprotective therapies in the NICU in term infants: present and future
10.1038/s41390-022-02295-2 · doi-reference
The therapeutic mechanisms of mesenchymal stem cells in ms-a review focusing on neuroprotective properties
10.3390/ijms25031365 · doi-reference
The relevance of BDNF for neuroprotection and neuroplasticity in multiple sclerosis
10.3389/fneur.2024.1385042 · doi-reference
Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients
10.1186/s12887-021-02890-y · doi-reference
Recent advances in stem cell therapies to address neuroinflammation, stem cell survival, and the need for rehabilitative therapies to treat traumatic brain injuries
10.3390/ijms22041978 · doi-reference
Preconditioning strategies to enhance neural stem cell-based therapy for ischemic stroke
10.3390/brainsci10110893 · doi-reference
Inflammatory mediators and GBM malignancy: Current scenario and future prospective
10.24976/discov.med.202335177.47 · doi-reference
Common sources of inflammation and their impact on hematopoietic stem cell biology
10.1007/s40778-020-00177-z · doi-reference
Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation
10.1038/s41598-021-87989-z · doi-reference
Haematopoietic stem cell transplantation for the treatment of multiple sclerosis: Recent advances
10.1007/s11910-023-01290-2 · doi-reference
The contribution of thymic tolerance to central nervous system autoimmunity
10.1007/s00281-020-00822-z · doi-reference
Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation
10.1038/sj.bmt.1704688 · doi-reference
Response and toxicity to cytarabine therapy in leukemia and lymphoma: from dose puzzle to pharmacogenomic biomarkers
10.3390/cancers13050966 · doi-reference
Viral encephalitis after hematopoietic cell transplantation: A systematic review
10.1016/j.jtct.2023.06.022 · doi-reference
Anxiety, depression, and mental health-related quality of life in survivors of pediatric allogeneic hematopoietic stem cell transplantation: a systematic review
10.1038/s41409-020-0782-z · doi-reference
Fatigue as mediator factor in ptsd-symptoms after allogeneic hematopoietic stem cell transplantation
10.3390/jcm12082756 · doi-reference
Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation
10.1186/s13014-022-02161-9 · doi-reference
A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients
10.1007/s11682-013-9221-8 · doi-reference
CNS manifestations in acute and chronic graft-versus-host disease
10.1093/brain/awae340 · doi-reference
Quality of life, physical functioning, and psychological distress of older adults undergoing hematopoietic stem cell transplantation
10.1016/j.jtct.2023.03.017 · doi-reference
The prospective effects of coping strategies on mental health and resilience at five months after hsct
10.3390/healthcare11131975 · doi-reference
Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease
10.1182/blood.2022016618 · doi-reference
Long-term brain status and cognitive impairment in children treated for high-risk acute lymphoblastic leukemia with and without allogeneic hematopoietic stem cell transplantation: A single-center study
10.1002/pbc.28224 · doi-reference
Impact of adequate day 30 post-pediatric hematopoietic stem cell transplantation vitamin d level on clinical outcome: An observational cohort study
10.1016/j.jtct.2022.05.032 · doi-reference
Change of white matter integrity in children with hematopoietic stem cell transplantation
10.1016/j.pediatrneurol.2020.06.008 · doi-reference
Growth in the face of overwhelming pressure: A narrative review of sibling donor experiences in pediatric hematopoietic stem cell transplant
10.1177/13674935211043680 · doi-reference
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT
10.1038/s41582-024-01050-x · doi-reference